Altitude travel with chronic lung disease
Altitude · pre-travel · Environmental
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Patients with COPD, interstitial lung disease, pulmonary hypertension or prior HAPE tolerate altitude poorly: the fall in inspired PO₂ worsens hypoxaemia and pulmonary-artery pressure. A pre-travel assessment predicts who will need supplemental oxygen or should avoid altitude.
Red flags
- Resting hypoxaemia at sea level
- Pulmonary hypertension
- Prior HAPE
- Recent exacerbation or unstable disease
Assessment
Differential diagnosis
- Deconditioning
- Cardiac disease
- Anaemia
- Pulmonary hypertension
- Obstructive sleep apnoea / obesity-hypoventilation
Investigations
- Spirometry / lung function and resting SpO₂
- Sea-level ABG in advanced disease
- Hypoxic challenge (altitude simulation) test where available — predicts in-flight/at-altitude PaO₂
- Echocardiography if pulmonary hypertension suspected
Management
- Assess severity and baseline oxygenation before travel; optimise the underlying disease first.
- Predict altitude PaO₂ (hypoxic challenge test) — arrange supplemental oxygen if predicted PaO₂ is low.
- Advise graded ascent, extra time to acclimatise, and avoiding heavy exertion early.
- Continue inhalers/therapy; consider acetazolamide prophylaxis if also AMS-prone (caution in CO₂ retention).
- Counsel on the symptoms of AMS/HAPE and a clear descent plan; those with severe disease or pulmonary hypertension may be advised NOT to travel to high altitude.
Drugs & doses
Supplemental oxygen (titrated to predicted need)
Continue usual bronchodilators / controller therapy
Acetazolamide 125 mg BD if AMS-prone (avoid in significant CO₂ retention)
Disposition
Outpatient respiratory assessment before travel; arrange oxygen provision and a written descent/action plan.
Complications & pitfalls
- Severe hypoxaemia at altitude
- Right-heart strain / decompensation
- HAPE (esp. prior history)
- Exacerbation of the underlying disease
Exam pearls
- A hypoxic-challenge (altitude simulation) test is the best predictor of who needs oxygen.
- Prior HAPE is the strongest risk factor for recurrence — plan prophylaxis and slow ascent.
- Use acetazolamide cautiously in CO₂-retaining COPD.
This is a pre-travel risk assessment: optimise the lung disease, predict oxygen needs, plan graded ascent, and advise the highest-risk patients against altitude travel.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.